Camargo A.
29
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2020 | 2 |
| 2021 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neuropsicología | 3 |
| Psicopatología | 1 |
| Neurología | 1 |
| Trastorno depresivo mayor | 1 |
| Psicología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 3 |
| Fisiología humana | 3 |
| Salud y seguridad personal | 2 |
| Microorganismos, hongos y algas | 2 |
| Temas específicos de historia natural de los animales | 1 |
| Problemas sociales y servicios a grupos | 1 |
| Grupos de personas | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 4 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Aline Siteneski | 5 |
| Rodrigues A.L.S. | 4 |
| Olescowicz G. | 2 |
| Pazini F.L. | 2 |
| Fraga D.B. | 2 |
| Brocardo P.S. | 2 |
| Dalmagro A.P. | 1 |
| Zeni A.L.B. | 1 |
| Wolin I.A.V. | 1 |
| Cunha M.P. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Prevalence of major depressive disorder in Portoviejo, Ecuador
ArticleAbstract: Major depressive disorder (MDD) is a debilitating neuropsychiatric disorder that affects more than 3Palabras claves:Depression, ECUADOR, major depressive disorder, Mental Health, PREVALENCEAutores:Aline Siteneski, Camargo A., Diego E. Portalanza, Juan Montalvo-Herdoíza, Mayra PereroFuentes:scopusA low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling
ArticleAbstract: Ketamine exhibits rapid and sustained antidepressant responses, but its repeated use may cause adverPalabras claves:Augmentation strategy, Corticosterone, Depression, Guanosine, KetamineAutores:Aline Siteneski, Camargo A., Dalmagro A.P., Rodrigues A.L.S., Wolin I.A.V., Zeni A.L.B.Fuentes:googlescopusPhysical exercise stimulates hippocampal mTORC1 and FNDC5/irisin signaling pathway in mice: Possible implication for its antidepressant effect
ArticleAbstract: Several lines of evidence have consistently indicated that physical exercise has antidepressant effePalabras claves:Depression, FNDC5, Irisin, mTORC1, physical exerciseAutores:Aline Siteneski, Brocardo P.S., Camargo A., Freitas A.E., Gruhn K., Olescowicz G., Rodrigues A.L.S.Fuentes:googlescopusmTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test
ArticleAbstract: The development of fast-acting antidepressants is crucial considering that conventional antidepressaPalabras claves:Creatine, Ketamine, mTORC1, Novelty-suppressed feeding testAutores:Aline Siteneski, Camargo A., Fraga D.B., Moretti M., Pazini F.L., Rodrigues A.L.S., Rosa J.M.Fuentes:googlescopusAntidepressant-like and pro-neurogenic effects of physical exercise: the putative role of FNDC5/irisin pathway
ArticleAbstract: Physical exercise has been shown to exert antidepressant effects, but the mechanisms underlying thisPalabras claves:Antidepressant, FNDC5, Irisin, neurogenesis, physical exerciseAutores:Aline Siteneski, Brocardo P.S., Camargo A., Cunha M.P., Fraga D.B., Gil-Mohapel J., Olescowicz G., Pazini F.L., Rodrigues A.L.S.Fuentes:googlescopus